… cytokine storm syndromes, such as reHLH associated with adult-onset Still’s disease [120],
or CRS secondary to CAR T cell therapies [28,121]. Several drugs are available, including …

… deterioration with the onset of fatal cytokine storm syndrome (CSS), which have increased
interest in CSS’s mechanisms, diagnosis and therapy. Although the prototypic concept of CSS …

… cytokine release syndrome suggests that early intervention is … high-quality evidence of
treatment efficacy is available, … from current clinical experience in cytokine storm syndromes. …

… Decisions surrounding the start of therapy in HLH/MAS patients are often the … intervention.
It is for this reason that the HLH/MAS workgroup focused its recommendations on treatment …

… syndrome and death. The objective of this study was to provide an evidence-based review of
the associated pathways and potential treatment … material for these activities can be read in …

… cytokines which are injurious to host cells similarly to what happens in other hyperinflammatory
syndromes characterized by cytokine storms… , but interventions targeting single cytokines …

… Chemokines are considered powerful biomarkers and therapeutic targets in a series of
diseases like atherosclerosis, multiple sclerosis, and colitis [23,24,25,26,27,28,29]. Thus, the …

… the use of potent immunomodulatory therapies both in the setting … Interventions targeting
single cytokines in sepsis, … immune response or cytokine storm syndrome can lead to pulmonary …

… cytokine storm or cytokine release syndrome (CRS), it is still unclear which molecular triggers
fuel the onset of the cytokine storm … It remains unknown if the observed cytokine storm and …

… in COVID-19 disease severity as well as potential therapeutic … between the cytokine storm
syndrome and severity leading … Interventions such as oxygen therapy, physical activity and …